RWRong Wu

Rong Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rong Wu has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Fenfen Xiang

    Department of Laboratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China

    20 shared publications
  • Xiangdong Kang

    Department of Laboratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    18 shared publications
  • Mengzhe Zhang

    Department of Laboratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China

    16 shared publications
  • Zixi Chen

    Laboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine

    13 shared publications
  • Xiaoxiao Li

    Department of Laboratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

    12 shared publications
  • Qing Gu

    Department of Laboratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

    6 shared publications

Latest Publications

  • Open Access

    A lactylation-related gene signature predicts prognosis and immunotherapy response in clear cell renal cell carcinoma based on machine learning and multi-omics analysis

    by Mengzhe Zhang, Yipeng Sun, Fenfen Xiang, Zhengrong Zhong, Rong Wu

    Clear cell renal cell carcinoma (ccRCC) is a highly heterogeneous malignancy with complex molecular features, posing significant challenges for accurate prognosis prediction and treatment stratification. Lactylation, an emerging epigenetic regulatory mechanism, plays a pivotal role in tumor progression and immune microenvironment remodeling. This study aims to develop a lactylation-related gene signature (LRGS) and systematically evaluate its prognostic value and potential for guiding clinical interventions in ccRCC. We developed a machine learning-derived lactylation signature using lactylation-related genes (LRGs) selected through bulk and single-cell RNA sequencing data. The model’s performance was subsequently validated using internal (TCGA-KIRC) and external (E-MTAB-1980) cohorts. The associations of LRGS with clinical characteristics, immune cell infiltration, and drug response were further analyzed. The functions of the key risk gene SHC1 were investigated using in vitro experiments. Ultimately, an 11-gene LRGS was identified that effectively predicts the prognosis of ccRCC patients. This model demonstrated robust predictive capability in an external dataset (AUC > 0.7). Univariate and multivariate analyses indicated that the model’s risk score was an independent predictor of clinical outcomes. The high-risk group exhibited significant infiltration of Tregs and a higher tumor immune dysfunction score, indicating a poorer responsiveness to immunotherapy. Finally, cell experiments confirmed that inhibiting SHC1 expression suppressed the proliferation and migration of ccRCC cells. In conclusion, we successfully constructed a novel LRGS, which provides a new perspective for risk stratification and personalized treatment of ccRCC.

  • Open Access

    Epidemiological characteristics of six respiratory pathogens in Putuo District of Shanghai from 2023 to 2024

    by Guotai Sun, Zixi Chen, Qing Gu, Jin Zheng, Fenfen Xiang, Xiaoxiao Li, Mengzhe Zhang, Jiawen Qian, Rong Wu

    This study aimed to investigate the epidemiological characteristics of respiratory pathogens in Putuo District, Shanghai, to provide evidence for clinical

  • Open Access

    Comparison of respiratory pathogen infections in hospitalized patients before and during the COVID-19 pandemic in Shanghai, China

    by Xiaoxiao Li, Jie Wang, Junhua Dai, Fenfen Xiang, Zixi Chen, Mengzhe Zhang, Jiawen Qian, Rong Wu

    This study aimed to assess the impact of COVID-19 on the prevalence of respiratory pathogens among hospitalized patients with respiratory tract infections in Shanghai, China. Patients with acute respiratory infections (ARIs) hospitalized at Putuo Hospital, Shanghai University of Traditional Chinese Medicine from January 2017 to December 2022 were collected. Indirect immunofluorescence assay (IFA) was used to detect the IgM antibody of nine common pathogens, including Chlamydia pneumoniae (CP), Mycoplasma pneumoniae (MP), parainfluenza virus (PIV), respiratory syncytial virus (RSV), influenza virus A (FluA), influenza virus B (FluB), adenovirus (ADV), Legionella pneumophila (Lp), and Coxiella burnetii (Cb). A total of 24,933 eligible patients were enrolled. The overall detection rate of respiratory pathogens in the pre-outbreak group (2017–2019, 32.05%) was significantly higher than that in the outbreak group (2020–2022, 11.48%, P < 0.001). MP (16.03%), Lp (2.43%), FluB (1.73%), and PIV (1.64%) were the main pathogens. Positivity for MP, FluB, and PIV declined significantly, whereas the detection rate of Lp was increased ( P < 0.05) during the 2020–2022 period compared with the 2017–2019 period. Children (73.21%) experienced a significantly higher infection rate than adolescents (65.35%), adults (25.20%), and older adults (15.40%). MP+PIV was the most common co-detection pattern. The detection of CP, MP, PIV, RSV, FluB, ADV, and Lp differed significantly between the two periods. From 2020 to 2022, the detection rates of CP, MP, PIV, RSV, FluB, and ADV decreased, whereas the detection of Lp increased. Knowledge of common pathogens’ dynamics could serve as a reference for further prevention and control of ARIs. IMPORTANCE: This study leverages the changes in the common respiratory spectrum pre-pandemic and during the COVID-19 pandemic in hospitalized patients in Shanghai. These data may serve as a scientific foundation for the prevention and management of ARIs. Doctors and policymakers should pay attention to the changes in the epidemic trends and types of respiratory pathogens and maintain monitoring of respiratory pathogens to better control the prevalence of respiratory pathogens.


  • Open Access

    Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis

    by Xiaoxiao Li, Fenfen Xiang, Tong Liu, Zixi Chen, Mengzhe Zhang, Jinpeng Li, Xiangdong Kang, Rong Wu

    The presence of dysbiotic cervicovaginal microbiota has been observed to be linked to the persistent development of cervical carcinogenesis mediated by the human papillomavirus (HPV). Nevertheless, the characteristics of the cervical microbiome in individuals diagnosed with cervical cancer (CC) are still not well understood. Comprehensive analysis was conducted by re-analyzing the cervical 16S rRNA sequencing datasets of a total of 507 samples from six previously published studies. We observed significant alpha and beta diversity differences in between CC, cervical intraepithelial neoplasia (CIN) and normal controls (NC), but not between HPV and NC in the combined dataset. Meta-analysis revealed that opportunistic pernicious microbes Streptococcus, Fusobacterium, Pseudomonas and Anaerococcus were enriched in CC, while Lactobacillus was depleted compared to NC. Members of Gardnerella, Sneathia, Pseudomonas, and Fannyhessea have significantly increased relative abundance compared to other bacteria in the CIN group. Five newly identified bacterial genera were found to differentiate CC from NC, with an area under the curve (AUC) of 0.8947. Moreover, co-occurrence network analysis showed that the most commonly encountered Lactobacillus was strongly negatively correlated with Prevotella. Overall, our study identified a set of potential biomarkers for CC from samples across different geographic regions. Our meta-analysis provided significant insights into the characteristics of dysbiotic cervicovaginal microbiota undergoing CC, which may lead to the development of noninvasive CC diagnostic tools and therapeutic interventions.


  • Open Access

    Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3

    by Xiaoxiao Li, Yunzhi Zhao, Fenfen Xiang, Xinpei Zhang, Zixi Chen, Mengzhe Zhang, Xiangdong Kang, Rong Wu

    Background: Inaccurate colposcopy diagnosis may lead to inappropriate management and increase the incidence of cervical cancer. This study aimed to evaluate the diagnostic accuracy of colposcopy in the detection of histologic cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in women with transformation zone type 3 (TZ3). Methods: Records from 764 patients with TZ3 who underwent colposcopy-directed biopsy and/or endocervical curettage in Putuo Hospital China between February 2020 and March 2023 were retrospectively collected. Colposcopy was carried out based on 2011 International Federation of Cervical Pathology and Colposcopy (IFCPC) and Colposcopy nomenclature. The diagnostic performance of colposcopy for identifying CIN2 + was evaluated compared with biopsies. The Kappa and McNemar tests were used to perform statistical analyses. Results: Among the study population, 11.0% had pathologic CIN2+. The relative sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of colposcopy for histologic CIN2 + were 51.2%, 96.5%, 64.2% and 94.1%, respectively. The senior colposcopists (80.6%) had a higher colposcopic accuracy to diagnose histologic CIN2 + than junior colposcopists (68.6%). In subgroup analyses, age group ≥ 60 years (70.3%) showed lowest diagnostic accuracy when compared with age groups of < 45 years (84.4%) and 45–59 years (74.9%). Conclusion: Our findings suggest an increased risk of diagnostic inaccuracy of colposcopy in identifying CIN2 + in those ≥ 60 years of age with TZ3, and the accuracy of colposcopy is required to be further improved.


  • Open Access

    Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19

    by Zixi Chen, Jinpeng Li, Jin Zheng, Fenfen Xiang, Xiaoxiao Li, Mengzhe Zhang, Xiangdong Kang, Rong Wu


  • Open Access

    Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer

    by Jinpeng Li, Zixi Chen, Qian Li, Rongrong Liu, Jin Zheng, Qing Gu, Fenfen Xiang, Xiaoxiao Li, Mengzhe Zhang, Xiangdong Kang, et al.

    Objective: The aim of this study was to identify the expression of miRNA and lymphocyte subsets in the blood of gastric cancer (GC) patients, elucidate their clinical significance in GC, and establish novel biomarkers for the early diagnosis and prognosis of GC. Methods: The expression of miRNAs in the serum of GC patients was screened using second-generation sequencing and detected using qRT-PCR. The correlation between miRNA expression and clinicopathological characteristics of GC patients was analyzed, and molecular markers for predicting cancer were identified. Additionally, flow cytometry was used to detect the proportion of lymphocyte subsets in GC patients compared to healthy individuals. The correlations between differential lymphocyte subsets, clinicopathological features of GC patients, and their prognosis were analyzed statistically. Results: The study revealed that hsa-miR-1306-5p, hsa-miR-3173-5p, and hsa-miR-296-5p were expressed at lower levels in the blood of GC patients, which is consistent with miRNA-seq findings. The AUC values of hsa-miR-1306-5p, hsa-miR-3173-5p, and hsa-miR-296-5p were found to be effective predictors of GC occurrence. Additionally, hsa-miR-296-5p was found to be negatively correlated with CA724. Furthermore, hsa-miR-1306-5p, hsa-miR-3173-5p, and hsa-miR-296-5p were found to be associated with the stage of the disease and were closely linked to the clinical pathology of GC. The lower the levels of these miRNAs, the greater the clinical stage of the tumor and the worse the prognosis of gastric cancer patients. Finally, the study found that patients with GC had lower absolute numbers of CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, and lymphocytes compared to healthy individuals. The quantity of CD4+ T lymphocytes and the level of the tumor marker CEA were shown to be negatively correlated. The ROC curve and multivariate logistic regression analysis demonstrated that lymphocyte subsets can effectively predict gastric carcinogenesis and prognosis. Conclusion: These miRNAs such as hsa-miR-1306-5p, hsa-miR-3173-5p, hsa-miR-296-5p and lymphocyte subsets such as the absolute numbers of CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, lymphocytes are down-regulated in GC and are closely related to the clinicopathological characteristics and prognosis of GC patients. They may serve as new molecular markers for predicting the early diagnosis and prognosis of GC patients.


  • Open Access

    Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression

    by Mengzhe Zhang, Fenfen Xiang, Yipeng Sun, Rongrong Liu, Qian Li, Qing Gu, Xiangdong Kang, Rong Wu

    Ursolic acid (UA), a natural pentacyclic triterpenoid, is known to exhibit various biological activities and anticancer effects. However, the underlying anticancer mechanism is not fully understood to date. The present study aimed to investigate the antimetastatic effect of UA through ADP‑ribosylation factor like GTPase 4C (ARL4C) in colon cancer. A lung metastasis model of colon cancer in nude mice was established through tail vein injection. A Cell Counting Kit‑8 assay was used to investigate the proliferation of colon cancer cells. Transwell assays were used to detect cell migration and invasion. The expression levels of proteins including ARL4C, matrix metallopeptidase 2 (MMP2), phosphorylated (p)‑AKT and p‑mTOR were measured using western blot analysis. Immunohistochemistry was used to determine the protein expression level in tissues. ARL4C ubiquitination levels were analysed using immunoprecipitation and western blotting. The results indicated that UA inhibits the metastasis of colon cancer in vivo and in vitro. The expression of ARL4C in human colon cancer tissue was significantly higher than that in adjacent tissues and its high expression level was associated with lymph node metastases and tumour stage. UA treatment significantly decreased ARL4C and MMP2 protein levels and inhibited the AKT/mTOR signalling pathway. Overexpression of ARL4C reversed the inhibitory effect of UA on the invasion and migration of HCT‑116 and SW480 cells, as well as the expression and secretion of MMP2 protein. In addition, UA and an AKT signalling pathway inhibitor (LY294002) induced the ubiquitination of the ARL4C protein, which was reversed by a proteasome inhibitor (MG‑132). Collectively, it was revealed in the present study that UA served as a novel solution to relieve colon cancer metastasis by inducing the ubiquitination‑mediated degradation of ARL4C by modulating the AKT signalling pathway. Thus, UA may be a promising treatment option to prolong the survival of patients with colon cancer metastasis.


  • Open Access

    Elevated expression of Toll-like receptor 4 and cytokines in both serum and myometrium at term may serve as promising biomarkers for uterine activation preceding labor

    by Zixi Chen, Jinpeng Li, Wenjuan Xu, Xiaomei Wu, Fenfen Xiang, Xiaoxiao Li, Mengzhe Zhang, Jin Zheng, Xiangdong Kang, Rong Wu

    Objective: Increased inflammation and cytokine levels are considered risk factors and promoters of preterm birth (PTB). However, the regulatory mechanism of pregnancy-related inflammation remains unclear. Toll-like receptor 4 (TLR4) plays a critical role in inflammatory responses in various diseases. Therefore, our study aimed to investigate whether TLR4 is involved in the inflammatory responses during uterine activation for labor, with the goal of identifying potential biomarkers for uterine activation at term.Materials and methods: We used flow cytometry to detect TLR4 expression on CD14+ maternal blood monocytes in the first, second, and third trimesters. ELISA was employed to measure TLR4 and cytokines levels in the maternal serum of term non-labor (TNL), term labor (TL) women and LPS induced preterm labor and PBS injected controls. TLR4siRNA was transfected into the human myometrial smooth muscle cells (HMSMCs), which were subsequently treated with IL-1β. The mRNA and protein levels of TLR4, uterine contraction-related protein connexin 43 (CX43), oxytocin receptor (OTR), MAPK/NF-κB signaling pathway, and cytokines were analyzed using qRT-PCR, western blotting, and immunohistochemistry.Results: The study revealed TLR4 expression on CD14+ maternal blood monocytes was higher in the third trimester group compared to the first and second trimester groups (p<0.001). Maternal serum concentrations of TLR4 and cytokines were significantly higher in the TL group than the TNL group (p<0.001). TLR4, OTR, CX43, activated MAPK/NF-κB expression, and cytokines levels were upregulated in TL group, and similarly significantly higher in the LPS-induced preterm group than in the control group. Using the HMSMCs we demonstrated that TLR4siRNA transfection suppressed contractility. Interfering with TLR4 expression reduced the expression of OTR, CX43, cytokines, and MAPK/NF-κB activation. There was a significant positive relationship between TLR4 expression and the inflammatory status in the myometrium. ROC analysis indicated that TLR4 and cytokines may serve as potential biomarkers for predicting uterine activation for labor.Conclusion: Our data suggest that TLR4 and cytokines can act as stimulators of uterine activation for labor at term. Furthermore, the MAPK/NF-κB pathway appears to be one of the potential signaling pathways mediating TLR4’s regulation of parturition initiation.


  • Open Access

    Ursolic Acid Inhibits the Growth of Gastric Cancer by Targeting KLF4/YAP1

    by Fenfen Xiang, Mengzhe Zhang, Wenbin Hao, Rongrong Liu, Qian Li, Qing Gu, Zhaowei Zhu, Zixi Chen, Xiaoxiao Li, Xiangdong Kang, et al.

    Krppel-like factor 4 (KLF4) is a zinc-finger transcription factor which has various mechanisms in different tumors. Ursolic acid (UA), a natural compound that exists in many herbs, is known to prevent tumor progression and has anticancer effects on many human cancers. The present study was to evaluate the antitumor effect of UA on gastric cancer (GC) through KLF4 and the Hippo pathway. Our data showed that UA inhibited the growth of GC in vivo and in vitro. UA treatment significantly increased the expression of KLF4 and decreased the expression of CTGF. The overexpression of KLF4 inhibited the proliferation and cell cycle of GC and decreased the expression of CTGF, whereas the knockdown of KLF4 attenuated the effects of UA. Furthermore, the inhibition of CTGF arrested tumor cells in G2/M which blocked proliferation progress. Confocal laser scanning and molecular simulation software MOE showed that KLF4 combined with YAP1 which may block the formation of the TEADs-YAP1 complex to interrupt the expression of CTGF and the downstream oncogenic process. In conclusion, UA can inhibit GC growth both in vivo and in vitro, and it activated KLF4 which may competitively bind with YAP1 against TEADs and block the oncogenic Hippo pathways.